Id |
Subject |
Object |
Predicate |
Lexical cue |
T108 |
0-37 |
Sentence |
denotes |
CT findings in patients with COVID-19 |
T109 |
38-168 |
Sentence |
denotes |
The CT findings of patients with COVID-19 in early and progressive stages are listed in Table 2 and shown in Figs. 2, 3, 4, and 5. |
T110 |
169-264 |
Sentence |
denotes |
In terms of CT characteristics, the major finding was the GGO in 38 (61.3%) of the 62 patients. |
T111 |
265-791 |
Sentence |
denotes |
In addition, GGO with consolidation was observed in 22 (35.5%) patients; rounded opacities were observed in 16 (25.8%) patients; a crazy-paving pattern was observed in 16 (25.8%) patients; an air bronchogram was observed in 14 (22.6%) patients; a halo sign was observed in 7 (11.3%) patients; a subpleural curvilinear line was observed in 6 (9.7%) patients; pleural effusion was observed in 2 (3.2%) patients; and consolidation, nodules, thoracic lymphadenopathy, and pulmonary fibrosis were observed in 1 (1.6%) patient each. |
T112 |
792-875 |
Sentence |
denotes |
No patient presented cavitation, a reticular pattern, or bronchial wall thickening. |
T113 |
876-1027 |
Sentence |
denotes |
Between the early-stage group and progress-stage group, there were no significant differences in the CT findings, except for the halo sign (p = 0.013). |
T114 |
1028-1121 |
Sentence |
denotes |
Specifically, the halo sign was found in only the early-stage group in 20.6% of the patients. |
T115 |
1122-1211 |
Sentence |
denotes |
Table 2 Comparison of CT findings and scores between two groups in patients with COVID-19 |
T116 |
1212-1289 |
Sentence |
denotes |
Variables Early-stage group (n = 34) Progressive-stage group (n = 28) p value |
T117 |
1290-1301 |
Sentence |
denotes |
CT findings |
T118 |
1302-1356 |
Sentence |
denotes |
Ground-glass opacity 22 (64.7%) 16 (57.1%) 0.543 (χ) |
T119 |
1357-1398 |
Sentence |
denotes |
Consolidation 1 (2.9%) 0 (0%) 1.000 (χ) |
T120 |
1399-1472 |
Sentence |
denotes |
Ground-glass opacity with consolidation 11 (32.4%) 11 (39.3%) 0.570 (χ) |
T121 |
1473-1498 |
Sentence |
denotes |
Reticular pattern 0 0 – |
T122 |
1499-1528 |
Sentence |
denotes |
Nodule 1 (2.9%) 0 1.000 (χ) |
T123 |
1529-1579 |
Sentence |
denotes |
Rounded opacities 10 (29.4%) 6 (21.4%) 0.475 (χ) |
T124 |
1580-1598 |
Sentence |
denotes |
Cavitation 0 0 – |
T125 |
1599-1651 |
Sentence |
denotes |
Crazy-paving pattern 8 (23.5%) 8 (28.6%) 0.652 (χ) |
T126 |
1652-1699 |
Sentence |
denotes |
Air bronchogram 8 (23.5%) 6 (21.4%) 0.844 (χ) |
T127 |
1700-1733 |
Sentence |
denotes |
Halo sign 7 (20.6%) 0 0.013 (χ) |
T128 |
1734-1767 |
Sentence |
denotes |
Bronchial wall thickening 0 0 – |
T129 |
1768-1826 |
Sentence |
denotes |
Subpleural curvilinear line 4 (11.8%) 2 (7.1%) 0.681 (χ) |
T130 |
1827-1874 |
Sentence |
denotes |
Thoracic lymphadenopathy 0 1 (3.6%) 0.452 (χ) |
T131 |
1875-1935 |
Sentence |
denotes |
Pleural effusion or thickening 1 (2.9%) 1 (3.6%) 1.000 (χ) |
T132 |
1936-1977 |
Sentence |
denotes |
Pulmonary fibrosis 0 1 (3.6%) 0.452 (χ) |
T133 |
1978-2037 |
Sentence |
denotes |
Max diameter of lesion (cm) 4.27 ± 2.66 5.83 ± 3.76 0.059 |
T134 |
2038-2068 |
Sentence |
denotes |
< 1 cm 0 1 (3.6) 0.201 (χ) |
T135 |
2069-2102 |
Sentence |
denotes |
1–2.9 cm 13 (38.2%) 5 (17.9%) |
T136 |
2103-2137 |
Sentence |
denotes |
3–4.9 cm 12 (35.3%) 10 (35.7%) |
T137 |
2138-2169 |
Sentence |
denotes |
> 5 cm 9 (26.5%) 12 (42.9%) |
T138 |
2170-2182 |
Sentence |
denotes |
Distribution |
T139 |
2183-2220 |
Sentence |
denotes |
Central 1 (2.9%) 1 (3.6%) 0.961 (χ) |
T140 |
2221-2254 |
Sentence |
denotes |
Peripheral 12 (35.3%) 9 (32.1%) |
T141 |
2255-2306 |
Sentence |
denotes |
Both central and peripheral 21 (61.8%) 18 (64.3%) |
T142 |
2307-2345 |
Sentence |
denotes |
CT score 4.79 ± 2.76 7.79 ± 4.62 0.004 |
T143 |
2346-2383 |
Sentence |
denotes |
0–5 27 (79.4%) 10 (35.7%) 0.004 (χ) |
T144 |
2384-2411 |
Sentence |
denotes |
6–10 6 (17.6%) 12 (42.9%) |
T145 |
2412-2431 |
Sentence |
denotes |
11–15 0 3 (10.7%) |
T146 |
2432-2457 |
Sentence |
denotes |
> 15 1 (2.9%) 3 (10.7%) |
T147 |
2458-2492 |
Sentence |
denotes |
COVID-19, coronavirus disease 2019 |
T148 |
2493-2789 |
Sentence |
denotes |
Fig. 2 A 56-year-old male with coronavirus disease 2019 in the early-stage group. a Axial non-contrast CT shows ground-glass opacities in the anterior segments of bilateral upper lobes. b Ground-glass opacity is also shown in the peripheral region of the lateral basal segment of left lower lobe. |
T149 |
2790-2869 |
Sentence |
denotes |
CT score = 1 (right upper lobe) + 1 (left upper lobe) + 1 (left lower lobe) = 3 |
T150 |
2870-3290 |
Sentence |
denotes |
Fig. 3 A 34-year-old female with coronavirus disease 2019 in the early-stage group. a Axial non-contrast CT shows halo sign in the dorsal segment of left lower lobe and multiple ground-glass opacities in the right upper lobe and the dorsal segment of the right lower lobe. b Sagittal non-contrast CT demonstrates multiple ground-glass opacities with consolidations in the right lung, mainly distributed in the periphery. |
T151 |
3291-3371 |
Sentence |
denotes |
CT score = 2 (right upper lobe) + 2 (right lower lobe) + 1 (left lower lobe) = 5 |
T152 |
3372-3736 |
Sentence |
denotes |
Fig. 4 A 40-year-old female with coronavirus disease 2019 in the progressive-stage group. a Axial non-contrast CT shows crazy-paving pattern in the anterior segment and consolidation in the posterior segment of right upper lobe. b Consolidations are noted in the bilateral lower lobes mainly in the peripheral regions, accompanied with subpleural curvilinear line. |
T153 |
3737-3864 |
Sentence |
denotes |
CT score = 3 (right upper lobe) + 1 (right middle lobe) + 3 (right lower lobe) + 1 (left upper lobe) + 3 (left lower lobe) = 11 |
T154 |
3865-4193 |
Sentence |
denotes |
Fig. 5 A 60-year-old male with coronavirus disease 2019 in the progressive-stage group. a Axial non-contrast CT in pulmonary window shows diffuse ground-glass opacities with consolidations in bilateral lungs. b Axial non-contrast CT in mediastinal window shows consolidations in bilateral lungs, with bilateral pleural effusion. |
T155 |
4194-4321 |
Sentence |
denotes |
CT score = 5 (right upper lobe) + 4 (right middle lobe) + 4 (right lower lobe) + 3 (left upper lobe) + 2 (left lower lobe) = 18 |
T156 |
4322-4678 |
Sentence |
denotes |
In terms of lesion size, lesions with a maximum diameter greater than 5 cm were found in 21 (33.9%) of 62 patients; lesions with a maximum diameter of 3–4.9 cm were found in 22 (35.5%) patients; lesions with a maximum diameter of 1–2.9 cm were found in 18 (29.0%) patients; and lesions with a maximum diameter less than 1 cm were found in 1 (1.6%) patient. |
T157 |
4679-4805 |
Sentence |
denotes |
There was no statistically significant difference in lesion size between the two groups of patients with COVID-19 (p = 0.059). |
T158 |
4806-5137 |
Sentence |
denotes |
Regarding the distribution of pulmonary parenchymal abnormalities, lesions that were mainly distributed in both the central and peripheral lung regions accounted for 62.9%; lesions distributed in the peripheral lung were present in 21 (33.9%) patients; and lesions distributed in the central lung were present in 2 (3.2%) patients. |
T159 |
5138-5308 |
Sentence |
denotes |
There was no statistically significant difference in the distribution of pulmonary parenchymal abnormalities between the two groups of patients with COVID-19 (p = 0.961). |